Overview

• Current newborn screening in Germany detects 19 rare diseases using a blood sample from a baby's heel, saving lives through early diagnosis and treatment.
• A new genomic screening initiative, led by Heidelberg and Mannheim researchers, aims to test for up to 200 genetic conditions starting in 2026 as part of a study, pending funding approval.
• Experts emphasize the need to limit testing to treatable conditions manifesting in childhood and to ensure secure storage of sensitive genetic data.
• Critics warn against private companies offering unregulated screenings, citing concerns about quality, transparency, and lack of connection to specialized treatment networks.
• The Deutsche Gesellschaft für Kinder- und Jugendmedizin plans to enhance current screenings by January 2025, reducing result turnaround times to 72 hours to improve treatment efficiency.